Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era

The American College of Physicians has issued an updated version of its living, rapid practice point guideline on the best treatment options for outpatients with confirmed COVID-19.MDedge News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news